Health and Fitness Health and Fitness
Thu, January 13, 2011
[ Thu, Jan 13th 2011 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of American Surgical Holdings, Inc.
[ Thu, Jan 13th 2011 ] - Market Wire
BioDuro Named to Deloitte Technology Fast 500 Asia Pacific 2010 Ranking
[ Thu, Jan 13th 2011 ] - Market Wire
The Law Office of Joseph Klein is Investigating P .. Duty by the Board of American Surgical Holdings,
[ Thu, Jan 13th 2011 ] - Market Wire
ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FRO .. MARKET AND TRANSFER TO OTCQB&;#8482; MARKETPLACE
[ Thu, Jan 13th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Investigates American Surgical Holdings, Inc. Buyout
[ Thu, Jan 13th 2011 ] - Market Wire
Sucampo Announces Resignation of Chief Financial Officer
[ Thu, Jan 13th 2011 ] - Market Wire
Medtronic Completes Acquisition of Ardian
[ Thu, Jan 13th 2011 ] - Market Wire
Covidien Supports FDA on Acetaminophen Safe Use
[ Thu, Jan 13th 2011 ] - Market Wire
Winter Weather Spells SAD for Some
[ Thu, Jan 13th 2011 ] - Market Wire
St. Jude Medical Announces Launch of the ViewMate .. Ultrasound System and ViewFlex Plus ICE Catheter
[ Thu, Jan 13th 2011 ] - Market Wire
Codexis to Announce Fourth Quarter 2010 Financial Results on February 3, 2011
[ Thu, Jan 13th 2011 ] - Market Wire
ADVISORY - Nordion to Release Fourth Quarter 2010 and Year-end Financial Results
[ Thu, Jan 13th 2011 ] - Market Wire
International Stem Cell Applauds Research Showing .. Potential Strategy for Treating Inherited Disease
[ Thu, Jan 13th 2011 ] - Market Wire
Obagi Medical Products Introduces Blue Peel RADIANCE and Nu-Derm Sun Shield SPF 50
[ Thu, Jan 13th 2011 ] - Market Wire
BioCryst Announces Peramivir Phase 3 Safety & Vir .. dy Results and Provides a Clinical Program Update
Wed, January 12, 2011
[ Wed, Jan 12th 2011 ] - Market Wire
Intuitive Surgical, Inc. Fourth Quarter and Year-End 2010 Earnings Conference Call
[ Wed, Jan 12th 2011 ] - Market Wire
CENTRIC HEALTH ANNOUNCES COURT APPROVAL OBTAINED ON ACQUISITION OF DEDICATED PHARMACY GROUP
[ Wed, Jan 12th 2011 ] - Market Wire
Last Days for North American Companies to Registe .. ings. Registration period ends on Friday, January
[ Wed, Jan 12th 2011 ] - Market Wire
Sanofi-aventis Enters Into Two Research & Develop .. With the University of California, San Francisco
[ Wed, Jan 12th 2011 ] - Market Wire
FDA Awards SDIX Method Equivalency for Salmonella Enteritidis Detection in Poultry Houses and Eggs
[ Wed, Jan 12th 2011 ] - Market Wire
MedImmune and Micromet Announce Initiation of Pha .. tibody MEDI-565 (MT111) in Patients with Advanced
[ Wed, Jan 12th 2011 ] - Market Wire
CytRx Raises $7 Million from Sale of Remaining Equity Interest in RXi Pharmaceuticals
[ Wed, Jan 12th 2011 ] - Market Wire
St. Jude Medical Announces Preliminary Fourth Quarter Revenue Results
[ Wed, Jan 12th 2011 ] - Market Wire
Wright Medical Group, Inc. Announces Launch of DARCO® Foot & Ankle Plating Line in Japan
[ Wed, Jan 12th 2011 ] - Market Wire
DSM and Codexis Sign Enzyme Supply Agreement
[ Wed, Jan 12th 2011 ] - Market Wire
Merck and PAREXEL Form Strategic Alliance Focused on Clinical Development of Biosimilar Candidates
[ Wed, Jan 12th 2011 ] - Market Wire
Salix Pharmaceuticals, Inc. and the Colon Cancer .. For Dummies® is Now Available for Free Download
[ Wed, Jan 12th 2011 ] - Market Wire
CIRC (Circulation Improving Resuscitation Care) Trial Concludes Successfully
[ Wed, Jan 12th 2011 ] - Market Wire
Biogen Idec geeft update over het bedrijf op beleggersbijeenkomst
[ Wed, Jan 12th 2011 ] - Market Wire
Biogen Idec proporciona informacin actualizada sobre el negocio durante reunin de inversores

Biogen Idec proporciona informacin actualizada sobre el negocio durante reunin de inversores


Published on 2011-01-12 03:41:46 - Market Wire
  Print publication without navigation


SAN FRANCISCO--([ BUSINESS WIRE ])--Durante una presentacin a los inversores en la 29 edicin anual de la conferencia sobre sanidad J. P. Morgan, el consejero delegado de [ Biogen Idec ] (NASDAQ: BIIB), George Scangos, Ph.D., destacar el progreso de la empresa en relacin con su estructura para el crecimiento y detallar los hitos que se alcanzarn en 2011 y aos sucesivos. El Dr. Scangos participa hoy a las 12:30 a.m. (hora peninsular espaola). Estar disponible la retransmisin por Internet de todos sus comentarios as como la correspondiente presentacin en diapositivas en la seccin de inversores de [ www.biogenidec.com ].

El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.

Contributing Sources